Chien-Hung Chen

Affiliations: 
ROC Air Force Academy 
Area:
Antenna, Radar, Cyber, Drone
Google:
"Chien-Hung Chen"

Parents

Sign in to add mentor
Jenshan Lin research scientist (Physics Tree)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Yen YH, Cheng YF, Wang JH, et al. (2021) Adherence to the modified Barcelona Clinic Liver Cancer guidelines: Results from a high-volume liver surgery center in East Asias. Plos One. 16: e0249194
Kuo YH, Wang JH, Hung CH, et al. (2021) Combining end-of-treatment HBsAg and baseline hepatitis B core-related antigen reduce HBV relapse rate after tenofovir cessation. Hepatology International
Chen CY, Huang CF, Cheng PN, et al. (2021) Factors associated with treatment failure of direct-acting antivirals for chronic hepatitis C - a real-world nationwide HCV Registry Program (TACR) in Taiwan. Liver International : Official Journal of the International Association For the Study of the Liver
Gu SH, Chen CH, Lin PL. (2021) Expression of protein tyrosine phosphatases and Bombyx embryonic development. Journal of Insect Physiology. 104198
Liu M, Tseng TC, Jun DW, et al. (2021) Transition rates to cirrhosis and liver cancer by age, gender, disease and treatment status in Asian chronic hepatitis B patients. Hepatology International
Chen CH, Chen CY, Wang JH, et al. (2020) Comparison of incidence of hepatocellular carcinoma between chronic hepatitis B patients with cirrhosis treated with entecavir or tenofovir in Taiwan - a retrospective study. American Journal of Cancer Research. 10: 3882-3895
Chen HY, Lu SN, Hung CH, et al. (2020) Predicting outcomes for recurrent hepatocellular carcinoma within Milan criteria after complete radiofrequency ablation. Plos One. 15: e0242113
Hu TH, Yueh-Hsia Chiu S, Tseng PL, et al. (2020) Five-year comparative risk of hepatocellular carcinoma development under entecavir or tenofovir treatment-naïve patients with chronic hepatitis B-related compensated cirrhosis in Taiwan. Alimentary Pharmacology & Therapeutics
Liu YW, Yong CC, Lin CC, et al. (2020) Liver resection of hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guideline recommendations: Results from a high-volume liver surgery center in East Asia. Journal of Surgical Oncology
Lin MT, Chang KC, Yen YH, et al. (2020) Chronic hepatitis B exhibited higher rate of hepatocellular carcinoma occurrence than hepatitis C in cirrhotic patients after effective antiviral treatment. Journal of the Formosan Medical Association = Taiwan Yi Zhi
See more...